• Home
  • SCOUT DS®
  • Technology
  • News & Events
  • Company
 
     
  • Diabetes: A Global Threat
     
  • Health Implications of Diabetes
     
  • Need for Improved Screening
     
  • A New Approach to Screening
     
  • No Blood, Fasting, or Waiting
  •  
  • Clinical Performance
     
  • Interpretation of Results
     
  • SCOUT DS - Video

No Blood, No Fasting, No Waiting.


SCOUT DS® Features:

  • Noninvasive
  • No blood draw or biohazards

  • No fasting
  • Allows opportunistic testing any time

  • Fast, immediate results
  • Facilitates patient counseling at point of service

  • Easy to use
  • Three-step procedure with factory calibration and on-board controls

  • Superior sensitivity
  • Contributes to earlier disease detection

  • No test strips to handle
  • Just enter pre-paid key test key


SCOUT DS has received approval from Health Canada for commercial distribution and it has been granted a CE Mark in the European Union.

US Caution: Federal law restricts the SCOUT DS system to investigational use only. Commercial distribution has not been granted by the US FDA. See SCOUT DS Operation Manual for descriptions of all relevant Warnings, Cautions, Contraindications, & Safety Information.


© Copyright 2011 VeraLight, Inc. All rights reserved. - Terms of Use